Sort
48,018 grants matching “immunotherapy”
Exploring DNA damage response pathways as targets for cancer therapy
$952,560Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA
Clinical Protocol and Data Management
$952,105Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · P30 · FY2024 · CA
Characterization Unit
$952,082Orit Rozenblatt-Rosen · Dana-Farber Cancer Inst · U2C · FY2019 · CA
Characterization Unit
$952,082Orit Rozenblatt-Rosen · Dana-Farber Cancer Inst · U2C · FY2020 · CA
Characterization Unit
$952,082David Liu · Dana-Farber Cancer Inst · U2C · FY2022 · CA
GENERAL CLINICAL RESEARCH CENTER
$951,937Medical University Of South Carolina · M01 · FY2000 · RR
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,710Megan Sykes · Columbia University Health Sciences · U01 · FY2021 · DK
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,710Megan Sykes · Columbia University Health Sciences · U01 · FY2022 · DK
Studying factors controlling cancer progression and immune recognition in mouse models
$951,640Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2025 · CA
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$951,356Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2024 · AI
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,344Megan Sykes · Columbia University Health Sciences · U01 · FY2020 · DK
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$951,202Allan D. Kirk · Duke University · U01 · FY2015 · AI
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$951,181Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$951,038Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2021 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2018 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2020 · CA
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
$950,805Angus W Thomson · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · AI
Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology
$950,637David G Kirsch · Duke University · R35 · FY2022 · CA
Novel Oral Yeast Immunotherapies for Ulcerative Colitis (Fast-track)
$950,520Zhiyong Yang · Fzata, Inc. · R44 · FY2023 · DK
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$950,045Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Determinants of response to cancer immunotherapy
$949,572Lawrence Fong · University Of California, San Francisco · R35 · FY2023 · CA
Determinants of response to cancer immunotherapy
$949,572Lawrence Fong · University Of California, San Francisco · R35 · FY2022 · CA
Characterization Unit
$949,009Alex K Shalek · Dana-Farber Cancer Inst · U2C · FY2018 · CA
Development of PSMA -based recombinant protein vaccines
$948,449Progenics Pharmaceuticals, Inc. · R44 · FY2004 · CA